Headlines

Artificial Intelligence Predicts Next Session’s Price Change For Tesla, Kodak, Chunghwa Telecom Co.

(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Tesla TSLA, Kodak KODK and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

Financial Asset Accuracy Close Price Prediction
Tesla (TSLA) 92.35% $180.24 $195.52
Kodak (KODK) 90.04% $3.97 $3.66
Chunghwa Telecom Co. (CHT) 89.07% $36.53 $37.23
Novo Nordisk A/S (NVO) 88.98% $125.9 $128.47
PayPal (PYPL) 88.85% $72.11 $72.84
Incyte Corporation (INCY) 88.83% $82.57 $84.05
NextEra Energy (NEE) 88.39% $85.17 $87.12
Exelon (EXC) 88.31% $42.81 $44.03
Datadog (DDOG) 88.26% $68.69 $64.5
Zoom (ZM) 87.82% $71.45 $72.61
Cigna (CI) 87.61% $329.02 $335.91
Twitter (TWTR) 84.13% $53.7 $54.1
Air Products and Chemicals (APD) 83.95% $312.51 $314.32
Regeneron Pharmaceuticals (REGN) 83.91% $746.2 $766.39
Rogers Communication (RCI) 83.79% $45.86 $46.64
Genmab (GMAB) 83.74% $45.4 $46.34
Amicus Therapeutics (FOLD) 83.73% $12.23 $12.27
Coca-Cola (KO) 83.67% $63.44 $64.9
Booking Holdings (BKNG) 83.55% $2040.22 $2053.55
VALE (VALE) 83.45% $16.78 $17.13
Ross Stores (ROST) 83.35% $116.75 $121.85
Caesars Entertainment (CZR) 83.32% $48.62 $48.63
Yamana Gold (AUY) 83.13% $5.48 $5.51
Church & Dwight Company (CHD) 82.97% $80.53 $83.54

1. Tesla (TSLA)

Shares of Tesla slid 9.6% in from $199.38 to $180.24 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 2% to $11,014.89, after two consecutive sessions in a row of losses.

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits. It provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; and purchase financing and leasing services. This segment is also involved in the provision of non-warranty after-sales vehicle services, sale of used vehicles, retail merchandise, and vehicle insurance, as well as sale of products to third party customers; services for electric vehicles through its company-owned service locations, and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners. This segment also offers service and repairs to its energy product customers, including under warranty; and various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 49.4% and 20.6%, respectively.

Previous days news about Tesla

  • Tesla plans to cut car production in shanghai as demand wanes: report. According to MarketWatch on Monday, 5 December, "Facing weaker demand in China, Tesla Inc. plans to reduce production at its Shanghai plant by possibly 20% in December, Bloomberg reported on Monday, citing sources. "
  • Tesla stock news and forecast: TSLA sinks after automaker cuts shanghai production. According to FXStreet on Monday, 5 December, "Last Thursday Tesla stock nearly cleared $199 before selling off and closing lower. ", "The news out of Shanghai caught investors off guard, because until now Tesla had been undergoing a global ramp up in production. "

More news about Tesla.

2. Kodak (KODK)

Shares of Kodak fell by a staggering 44.08% in from $7.1 to $3.97 at 18:21 EST on Tuesday, after three successive sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, following the last session’s downward trend.

Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, and packaging. The Digital Printing segment provides electrophotographic printing solutions, such as The ASCEND and NEXFINITY printers; prosper products, including the PROSPER 6000 Press, PROSPER Writing Systems, PROSPER press systems, and PROSPER components; versamark products; and PRINERGY workflow production software. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, and advanced materials and functional printing businesses. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. The company engages in the operation of Eastman Business Park, a technology center and industrial complex. It sells its products and services through direct sales, third party resellers, dealers, channel partners, and distributors. Eastman Kodak Company was founded in 1880 and is headquartered in Rochester, New York.

Volatility

Kodak’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.55%, a negative 2.03%, and a positive 2.82%.

Kodak’s highest amplitude of average volatility was 1.02% (last week), 3.31% (last month), and 2.82% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 1.18B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Kodak’s stock is considered to be overbought (>=80).

Moving Average

Kodak’s worth is way below its 50-day moving average of $5.12 and way under its 200-day moving average of $5.18.

More news about Kodak.

3. Chunghwa Telecom Co. (CHT)

Shares of Chunghwa Telecom Co. rose 9.14% in from $33.47 to $36.53 at 18:21 EST on Tuesday, after four sequential sessions in a row of gains. NYSE is falling 0.95% to $15,328.44, following the last session’s downward trend.

Chunghwa Telecom Co., Ltd., together with its subsidiaries, provides telecommunication services in Taiwan and internationally. It operates through Domestic Fixed Communications Business, Mobile Communications Business, Internet Business, International Fixed Communications Business, and Others segments. The company offers local and domestic long-distance telephone, broadband access, and related services; information and communication technology and VAS services; and interconnection with its fixed-line network to other mobile and fixed-line operators. It also provides mobile; HiNet Internet, data communication, and cloud; Internet data center; and international long-distance telephone and data services. In addition, the company distributes and sells mobile handsets, data cards, electronic materials, and computing and business machinery equipment and software; designs, develops, manufactures, sells, and services semiconductor testing components, printed circuit boards, and electronic components and finished products, and automatic license plate recognition software and hardware products. Further, it offers real estate development and property management; system, network, and communications integration; intelligent buildings and energy network; digital information supply and advertisement; property and liability insurance agency; family education; computing equipment installation; management consultancy; data processing; telecommunication engineering; Internet identify; and information and communication solution services. Additionally, the company provides software design services, and Internet contents production and play services; motion picture production and distribution; and energy saving solutions and international circuits, and services for electronic parts and machinery processed products. The company was incorporated in 1996 and is headquartered in Taipei City, Taiwan.

Moving Average

Chunghwa Telecom Co.’s value is higher than its 50-day moving average of $36.03 and way below its 200-day moving average of $41.05.

More news about Chunghwa Telecom Co..

4. Novo Nordisk A/S (NVO)

Shares of Novo Nordisk A/S jumped 9.42% in from $115.06 to $125.90 at 18:21 EST on Tuesday, after five successive sessions in a row of gains. NYSE is dropping 0.95% to $15,328.44, following the last session’s downward trend.

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

More news about Novo Nordisk A/S.

5. PayPal (PYPL)

Shares of PayPal fell 7.39% in from $77.86 to $72.11 at 18:21 EST on Tuesday, after two successive sessions in a row of losses. NASDAQ is falling 2% to $11,014.89, after two successive sessions in a row of losses.

PayPal Holdings, Inc. operates a technology platform that enables digital payments on behalf of merchants and consumers worldwide. It provides payment solutions under the PayPal, PayPal Credit, Braintree, Venmo, Xoom, Zettle, Hyperwallet, Honey, and Paidy names. The company's payments platform allows consumers to send and receive payments in approximately 200 markets and in approximately 100 currencies, withdraw funds to their bank accounts in 56 currencies, and hold balances in their PayPal accounts in 25 currencies. PayPal Holdings, Inc. was founded in 1998 and is headquartered in San Jose, California.

Moving Average

PayPal’s worth is way under its 50-day moving average of $87.03 and way under its 200-day moving average of $91.62.

More news about PayPal.

6. Incyte Corporation (INCY)

Shares of Incyte Corporation rose 8.39% in from $76.18 to $82.57 at 18:21 EST on Tuesday, after four consecutive sessions in a row of gains. NASDAQ is dropping 2% to $11,014.89, after two sequential sessions in a row of losses.

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naïve chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; Cellenkos, Inc.; and Nimble Therapeutics, as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Moving Average

Incyte Corporation’s worth is way higher than its 50-day moving average of $73.36 and way higher than its 200-day moving average of $74.48.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.3%, now sitting on 3.33B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 480% and 21.8%, respectively.

More news about Incyte Corporation.

7. NextEra Energy (NEE)

Shares of NextEra Energy jumped by a staggering 10.1% in from $77.36 to $85.17 at 18:21 EST on Tuesday, after two successive sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, following the last session’s downward trend.

NextEra Energy, Inc., through its subsidiaries, generates, transmits, distributes, and sells electric power to retail and wholesale customers in North America. The company generates electricity through wind, solar, nuclear, coal, and natural gas facilities. It also develops, constructs, and operates long-term contracted assets that consists of clean energy solutions, such as renewable generation facilities, battery storage projects, and electric transmission facilities; sells energy commodities; and owns, develops, constructs, manages and operates electric generation facilities in wholesale energy markets. As of December 31, 2021, the company had approximately 28,564 megawatts of net generating capacity; approximately 77,000 circuit miles of transmission and distribution lines; and 696 substations. It serves approximately 11 million people through approximately 5.7 million customer accounts in the east and lower west coasts of Florida. The company was formerly known as FPL Group, Inc. and changed its name to NextEra Energy, Inc. in 2010. The company was founded in 1925 and is headquartered in Juno Beach, Florida.

Volatility

NextEra Energy’s last week, last month’s, and last quarter’s current intraday variation average was 0.44%, 0.42%, and 1.70%.

NextEra Energy’s highest amplitude of average volatility was 1.19% (last week), 1.45% (last month), and 1.70% (last quarter).

More news about NextEra Energy.

8. Exelon (EXC)

Shares of Exelon rose by a staggering 16.81% in from $36.65 to $42.81 at 18:21 EST on Tuesday, following the last session’s upward trend. NASDAQ is falling 2% to $11,014.89, after two consecutive sessions in a row of losses.

Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services. Additionally, it is involved in the purchase and regulated retail sale of electricity and natural gas; and transmission and distribution of electricity, and distribution of natural gas to retail customers. Further, the company offers support services, including legal, human resources, information technology, financial, supply management, accounting, engineering, customer operations, distribution and transmission planning, asset management, system operations, and power procurement services. It serves distribution utilities, municipalities, cooperatives, and financial institutions, as well as commercial, industrial, governmental, and residential customers. Exelon Corporation was incorporated in 1999 and is headquartered in Chicago, Illinois.

Moving Average

Exelon’s worth is way above its 50-day moving average of $38.39 and under its 200-day moving average of $43.68.

Volatility

Exelon’s last week, last month’s, and last quarter’s current intraday variation average was 0.76%, 0.58%, and 1.67%.

Exelon’s highest amplitude of average volatility was 1.14% (last week), 1.31% (last month), and 1.67% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Exelon’s stock is considered to be oversold (<=20).

More news about Exelon.

9. Datadog (DDOG)

Shares of Datadog slid 1.41% in from $69.67 to $68.69 at 18:21 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ is falling 2% to $11,014.89, after two sequential sessions in a row of losses.

Datadog, Inc. provides monitoring and analytics platform for developers, information technology operations teams, and business users in the cloud in North America and internationally. The company's SaaS platform integrates and automates infrastructure monitoring, application performance monitoring, log management, and security monitoring to provide real-time observability of its customers technology stack. Its platform also provides user experience monitoring, network performance monitoring, cloud security, developer-focused observability, and incident management, as well as a range of shared features, such as dashboards, analytics, collaboration tools, and alerting capabilities. The company was incorporated in 2010 and is headquartered in New York, New York.

Sales Growth

Datadog’s sales growth is 53.2% for the present quarter and 37% for the next.

Volatility

Datadog’s last week, last month’s, and last quarter’s current intraday variation average was 0.43%, 0.38%, and 3.41%.

Datadog’s highest amplitude of average volatility was 3.59% (last week), 4.39% (last month), and 3.41% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 23.1% and a drop 30% for the next.

Moving Average

Datadog’s value is way below its 50-day moving average of $80.75 and way below its 200-day moving average of $105.81.

More news about Datadog.

10. Zoom (ZM)

Shares of Zoom fell by a staggering 12.12% in from $81.3 to $71.45 at 18:21 EST on Tuesday, after four successive sessions in a row of losses. NASDAQ is sliding 2% to $11,014.89, after two consecutive sessions in a row of losses.

Zoom Video Communications, Inc. provides unified communications platform in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. The company offers Zoom Meetings that offers HD video, voice, chat, and content sharing through mobile devices, desktops, laptops, telephones, and conference room systems; Zoom Phone, an enterprise cloud phone system; and Zoom Chat enables users to share messages, images, audio files, and content in desktop, laptop, tablet, and mobile devices. It also provides Zoom Rooms, a software-based conference room system; Zoom Hardware-as-a-Service allows users to access video communication technology from third party equipment; Zoom Conference Room Connector, a gateway for SIP/H.323 endpoints to join Zoom meetings; Zoom Events, which enables users to manage and host internal and external virtual events; OnZoom, a prosumer-focused virtual event platform and marketplace for Zoom users to create, host, and monetize online events; and Zoom Webinars to provide video presentations to large audiences from many devices. In addition, the company offers Zoom Developer Platform that enables developers, platform integrators, service providers, and customers to build apps and integrations using Zoom's video-based communications solutions, as well as integrate Zoom's technology into their products and services; Zoom App Marketplace, which helps developers to publish their apps, as well as third-party integrations of Zoom; and Zoom Contact Center, an omnichannel contact center solution. It serves individuals; and education, entertainment/media, enterprise infrastructure, finance, government, healthcare, manufacturing, non-profit/not for profit and social impact, retail/consumer products, and software/Internet industries. The company was formerly known as Zoom Communications, Inc. and changed its name to Zoom Video Communications, Inc. in May 2012. The company was incorporated in 2011 and is headquartered in San Jose, California.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zoom’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 4.22B for the twelve trailing months.

Volatility

Zoom’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.32%, a negative 0.15%, and a positive 2.61%.

Zoom’s highest amplitude of average volatility was 4.13% (last week), 4.24% (last month), and 2.61% (last quarter).

More news about Zoom.

11. Cigna (CI)

Shares of Cigna rose 1.42% in from $324.41 to $329.02 at 18:21 EST on Tuesday, after four consecutive sessions in a row of gains. NYSE is falling 0.95% to $15,328.44, following the last session’s downward trend.

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 4.6% and 1.6%, respectively.

More news about Cigna.

12. Twitter (TWTR)

Shares of Twitter dropped 0% in from $53.7 to $53.70 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.95% to $15,328.44, following the last session’s downward trend.

Twitter, Inc. operates as a platform for public self-expression and conversation in real-time. The company's primary product is Twitter, a platform that allows users to consume, create, distribute, and discover content. It also provides promoted products that enable advertisers to promote brands, products, and services, as well as enable advertisers to target an audience based on various factors, including who an account follows and actions taken on its platform, such as Tweets created and engagement with Tweets. Its promoted products consist of promoted ads and Twitter Amplify, Follower Ads, and Twitter takeover. In addition, the company offers monetization products for creators, including Tips to directly send small one-time payments on Twitter using various payment methods, including bitcoin; Super Follows, a paid monthly subscription, which includes bonus content, exclusive previews, and perks as a way to support and connect with creators on Twitter; and Ticketed Spaces to support creators on Twitter for their time and effort in hosting, speaking, and moderating the public conversation on Twitter Spaces. Further, it offers products for developers and data partners comprising Twitter Developer Platform, a platform that enables developers to build tools for people and businesses using its public application programming interface; and paid access to Twitter data for partners with commercial use cases. Twitter, Inc. was founded in 2006 and is based in San Francisco, California.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.2%, now sitting on 5.23B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 135.2% and 24.2%, respectively.

Moving Average

Twitter’s worth is way above its 50-day moving average of $41.24 and way above its 200-day moving average of $40.34.

Previous days news about Twitter

  • Dogecoin co-founder says twitter suspending meme accounts spreading 'positivity:' Elon Musk responds. According to Benzinga on Monday, 5 December, "Why It’s Important: Last week, Musk announced that Twitter users could see a drop in their follower count as the microblogging site is purging spam and fraudulent accounts.", "While mentioning the reason behind relaunching Twitter Blue, Musk said that the platform isn’t doing well at surfacing tweets from less prominent handles as it’s almost impossible to distinguish between humans and bots/trolls."

More news about Twitter.

13. Air Products and Chemicals (APD)

Shares of Air Products and Chemicals jumped by a staggering 12.49% in from $277.81 to $312.51 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.95% to $15,328.44, following the last session’s downward trend.

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasification, metals, manufacturing, food and beverage, electronics, magnetic resonance imaging, energy production and refining, and metals. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. Air Products and Chemicals, Inc. has a strategic collaboration with Baker Hughes Company to develop hydrogen compression systems. The company was founded in 1940 and is headquartered in Allentown, Pennsylvania.

Sales Growth

Air Products and Chemicals’s sales growth for the current quarter is 13.5%.

More news about Air Products and Chemicals.

14. Regeneron Pharmaceuticals (REGN)

Shares of Regeneron Pharmaceuticals dropped 0.55% in from $750.33 to $746.20 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is falling 2% to $11,014.89, after two successive sessions in a row of losses.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Yearly Top and Bottom Value

Regeneron Pharmaceuticals’s stock is valued at $746.20 at 18:21 EST, under its 52-week high of $769.63 and way above its 52-week low of $538.01.

Volatility

Regeneron Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was 0.84%, 0.12%, and 1.69%.

Regeneron Pharmaceuticals’s highest amplitude of average volatility was 1.20% (last week), 1.00% (last month), and 1.69% (last quarter).

Sales Growth

Regeneron Pharmaceuticals’s sales growth is 2.3% for the ongoing quarter and negative 36.4% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 34% and a negative 51.6%, respectively.

More news about Regeneron Pharmaceuticals.

15. Rogers Communication (RCI)

Shares of Rogers Communication jumped 7.55% in from $42.64 to $45.86 at 18:21 EST on Tuesday, after two consecutive sessions in a row of gains. NYSE is sliding 0.95% to $15,328.44, following the last session’s downward trend.

Rogers Communications Inc. operates as a communications and media company in Canada. It operates through three segments: Wireless, Cable, and Media. The company offers mobile Internet access, wireless voice and enhanced voice, device and accessory financing, wireless home phone, device protection, e-mail, global voice and data roaming, bridging landline, machine-to-machine and Internet of Things solutions, and advanced wireless solutions for businesses, as well as device delivery services; and postpaid and prepaid services under the Rogers, Fido, and chatr brands to approximately 11.3 million subscribers. It also provides Internet and WiFi services; smart home monitoring services, such as monitoring, security, automation, energy efficiency, and smart control through a smartphone app. In addition, the company offers local and network TV; on-demand television; cloud-based digital video recorders; voice-activated remote controls, and integrated apps; personal video recorders; linear and time-shifted programming; digital specialty channels; 4K television programming; and televised content on smartphones, tablets, and personal computers, as well as operates Ignite TV and Ignite TV app. Further, it provides residential and small business local telephony services; calling features, such as voicemail, call waiting, and long distance; voice, data networking, Internet protocol, and Ethernet services; private networking, Internet, IP voice, and cloud solutions; optical wave and multi-protocol label switching services; IT and network technologies; and cable access network services. The company also owns Toronto Blue Jays and the Rogers Centre event venue; and operates Sportsnet ONE, Sportsnet 360, Sportsnet World, Citytv, OMNI, FX (Canada), FXX (Canada), and OLN television networks, as well as 55 AM and FM radio stations. The company was founded in 1960 and is headquartered in Toronto, Canada.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Rogers Communication’s stock is considered to be overbought (>=80).

Volatility

Rogers Communication’s last week, last month’s, and last quarter’s current intraday variation average was 0.80%, 0.59%, and 1.40%.

Rogers Communication’s highest amplitude of average volatility was 1.63% (last week), 1.15% (last month), and 1.40% (last quarter).

Moving Average

Rogers Communication’s worth is way above its 50-day moving average of $40.52 and below its 200-day moving average of $48.15.

More news about Rogers Communication.

16. Genmab (GMAB)

Shares of Genmab rose by a staggering 14.36% in from $39.7 to $45.40 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is sliding 2% to $11,014.89, after two consecutive sessions in a row of losses.

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and DuoHexaBody-CD37 for treating hematological malignancies. The company's also develops products, which is in Phase 2 comprise Teclistamab for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. In addition, it has approximately 20 active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with CureVac AG for the research and development of differentiated mRNA-based antibody products; AbbVie for the development of epcoritamab; and collaborations with BioNTech, Janssen, Novo Nordisk A/S, BliNK Biomedical SAS, and Bolt Biotherapeutics, Inc. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.

Volatility

Genmab’s last week, last month’s, and last quarter’s current intraday variation average was 1.25%, 0.87%, and 1.76%.

Genmab’s highest amplitude of average volatility was 1.98% (last week), 1.58% (last month), and 1.76% (last quarter).

Sales Growth

Genmab’s sales growth is 26.8% for the ongoing quarter and 31.8% for the next.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 492.6% and 1252.9%, respectively.

More news about Genmab.

17. Amicus Therapeutics (FOLD)

Shares of Amicus Therapeutics rose by a staggering 18.74% in from $10.3 to $12.23 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 2% to $11,014.89, after two successive sessions in a row of losses.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.3%, now sitting on 321.14M for the twelve trailing months.

Sales Growth

Amicus Therapeutics’s sales growth is 5.1% for the current quarter and 15.5% for the next.

More news about Amicus Therapeutics.

18. Coca-Cola (KO)

Shares of Coca-Cola rose 6.68% in from $59.47 to $63.44 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is falling 0.95% to $15,328.44, following the last session’s downward trend.

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks; flavored and enhanced water, and sports drinks; juice, dairy, and plant–based beverages; tea and coffee; and energy drinks. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, Fanta, Fresca, Schweppes, Sprite, Thums Up, Aquarius, Ciel, dogadan, Dasani, glacéau smartwater, glacéau vitaminwater, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, Minute Maid Pulpy, Simply, Ayataka, BODYARMOR, Costa, FUZE TEA, Georgia, and Gold Peak brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Yearly Top and Bottom Value

Coca-Cola’s stock is valued at $63.44 at 18:21 EST, under its 52-week high of $67.20 and way higher than its 52-week low of $54.02.

Volatility

Coca-Cola’s last week, last month’s, and last quarter’s current intraday variation average was 0.66%, 0.44%, and 0.98%.

Coca-Cola’s highest amplitude of average volatility was 0.83% (last week), 0.76% (last month), and 0.98% (last quarter).

Moving Average

Coca-Cola’s worth is higher than its 50-day moving average of $58.77 and above its 200-day moving average of $61.66.

More news about Coca-Cola.

19. Booking Holdings (BKNG)

Shares of Booking Holdings jumped by a staggering 10.86% in from $1840.36 to $2,040.22 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is falling 2% to $11,014.89, after two sequential sessions in a row of losses.

Booking Holdings Inc. offers online reservations for travel and restaurants worldwide. Booking.com offers accommodation bookings online; Rentalcars.com provides rental car services online; Priceline which allows customers to make travel reservations online for hotel, flight and rental cars. Agoda, which offers online accommodations reservation, flight, ground transport, and activity reservation services, is also available. KAYAK is an online price comparison site that lets consumers search for and compare prices on travel itineraries. This includes information about rental cars, airline tickets, hotel reservations, and accommodation. OpenTable allows customers to book online restaurants. It also offers insurance and management services for consumers and travel service providers. The original name of the company was The Priceline Group Inc., but it changed its name in February 2018 to Booking Holdings Inc. It was established in 1997. The headquarters are located in Norwalk in Connecticut.

Volatility

Booking Holdings’s last week, last month’s, and last quarter’s current intraday variation average was 1.25%, 0.57%, and 1.98%.

Booking Holdings’s highest amplitude of average volatility was 1.72% (last week), 1.61% (last month), and 1.98% (last quarter).

Revenue growth

The year-over-year growth in quarterly revenue was 98.8%. We now have 14.65B of revenues for the 12 trailing months.

Classification of Stock Prices

The stochastic oscillator is a helpful indicator for overbought or oversold situations.

Booking Holdings is overbought (>=80).

More news about Booking Holdings.

20. VALE (VALE)

Shares of VALE jumped by a staggering 20.72% in from $13.9 to $16.78 at 18:21 EST on Tuesday, after two consecutive sessions in a row of losses. NYSE is dropping 0.95% to $15,328.44, following the last session’s downward trend.

Together with its subsidiaries Vale S.A. produces and sells ironore and ironore pellets to be used in steelmaking both in Brazil and abroad. Ferrous Minerals, and Base Metals are the segments that make up the company. Ferrous Minerals produces ferrous minerals, such as iron ore pellets and ferroalloys. It also provides logistical services. Base Metals produces and extracts nickel, along with its byproducts such as cobalt and precious metals. The former name of the company was Companhia Vale Do Rio Doce. In May 2009, Vale S.A. took over. Vale S.A. was established in 1942. It is located in Rio de Janeiro in Brazil.

Moving Average

VALE’s value is way above its 50-day moving average of $13.10 and above its 200-day moving average of $15.72.

More news about VALE.

21. Ross Stores (ROST)

Shares of Ross Stores rose by a staggering 25.54% in from $93 to $116.75 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is falling 2% to $11,014.89, after two successive sessions in a row of losses.

Ross Stores, Inc., together with its subsidiaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dd's DISCOUNTS brand names. Its stores primarily offer apparel, accessories, footwear, and home fashions. The company's Ross Dress for Less stores sell its products at department and specialty stores primarily to middle income households; and dd's DISCOUNTS stores sell its products at department and discount stores for households with moderate income. As of September 28, 2022, it operated approximately 2,000 stores under the Ross Dress for Less and dd's DISCOUNTS name in 40 states, the District of Columbia, and Guam. Ross Stores, Inc. was incorporated in 1957 and is headquartered in Dublin, California.

Yearly Top and Bottom Value

Ross Stores’s stock is valued at $116.75 at 18:21 EST, under its 52-week high of $119.48 and way above its 52-week low of $69.24.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Ross Stores’s stock is considered to be overbought (>=80).

Volatility

Ross Stores’s last week, last month’s, and last quarter’s current intraday variation average was 0.56%, 1.24%, and 1.87%.

Ross Stores’s highest amplitude of average volatility was 0.56% (last week), 1.96% (last month), and 1.87% (last quarter).

More news about Ross Stores.

22. Caesars Entertainment (CZR)

Shares of Caesars Entertainment rose by a staggering 10.58% in from $43.97 to $48.62 at 18:21 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ is dropping 2% to $11,014.89, after two sequential sessions in a row of losses.

Caesars Entertainment, Inc. operates as a gaming and hospitality company in the United States. The company operates casinos comprising poker, keno, and race and online sportsbooks; dining venues, bars, nightclubs, and lounges; hotels; and entertainment venues. It also provides staffing and management services; accessories, souvenirs, and decorative items through retail stores; and online sports betting and iGaming services. As of December 31,2021, the company owned, leased, and managed 52 domestic properties in 16 states, consisting of approximately 55,700 slot machines, video lottery terminals, and e-tables; 2,900 table games; and 47,700 hotel rooms. Caesars Entertainment, Inc. was founded in 1937 and is based in Reno, Nevada.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 10.39B for the twelve trailing months.

More news about Caesars Entertainment.

23. Yamana Gold (AUY)

Shares of Yamana Gold jumped by a staggering 12.3% in from $4.88 to $5.48 at 18:21 EST on Tuesday, after two successive sessions in a row of losses. NYSE is dropping 0.95% to $15,328.44, following the last session’s downward trend.

Yamana Gold Inc., together with its subsidiaries, operates as a precious metal producer. It has gold and silver production, development-stage properties, exploration properties, and land positions throughout the Americas, including Canada, Brazil, Chile, and Argentina. The company was formerly known as Yamana Resources Inc. and changed its name to Yamana Gold Inc. in August 2003. Yamana Gold Inc. was founded in 2003 and is headquartered in Toronto, Canada.

Moving Average

Yamana Gold is worth more than its moving average for 50 days of $4.76, and its moving average for 200 days of $5.03.

Sales Growth

Yamana Gold’s sales growth for the current quarter is negative 8%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 6.6%, now sitting on 1.85B for the twelve trailing months.

Volatility

Yamana Gold’s last week, last month’s, and last quarter’s current intraday variation average was 2.54%, 0.81%, and 2.90%.

Yamana Gold’s highest amplitude of average volatility was 2.72% (last week), 2.28% (last month), and 2.90% (last quarter).

More news about Yamana Gold.

24. Church & Dwight Company (CHD)

Shares of Church & Dwight Company jumped by a staggering 10.42% in from $72.93 to $80.53 at 18:21 EST on Tuesday, after two successive sessions in a row of losses. NYSE is dropping 0.95% to $15,328.44, following the last session’s downward trend.

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Church & Dwight Company’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 5.3% and positive 7.5% for the next.

Moving Average

Church & Dwight Company’s worth is higher than its 50-day moving average of $75.98 and way below its 200-day moving average of $90.25.

More news about Church & Dwight Company.

Leave a Reply

Your email address will not be published. Required fields are marked *